Avid Bioservices, Inc. reports $0.31 million Q4 loss

Avid Bioservices, Inc. [CDMO] has reported fiscal Q4 loss of $0.31 million.

On a per-share basis, the DE based company said its diluted earnings are $0.00.

The Pharmaceutical Preparations firm posted revenue of $39.80 million in this period.